Literature DB >> 23917219

Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways.

Jamie F Lu1, Frederick Luk, Joyce Gong, Ritu Jaiswal, Georges E R Grau, Mary Bebawy.   

Abstract

Multidrug resistance (MDR) is a major impediment to the overall success of chemotherapy in clinical oncology. MDR has been primarily attributed by the ATP-dependent transmembrane proteins, P-glycoprotein (P-gp, ABCB1) and Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1). These proteins maintain sublethal concentrations of intracellular chemotherapeutics by virtue of their drug efflux capacity. In this study, we report the acquisition and dissemination of functional MRP1 via microparticle (MP) mediated intercellular transfer. After we showed the transfer and functionality of P-gp in drug sensitive recipient cells, we report the transfer and time-dependent functionality of MRP1 in drug sensitive leukaemia cells following exposure to MPs shed by MRP1-overexpressing MDR cells. We also demonstrate a remarkable capacity for MPs shed from cells with a P-gp dominant resistance profile to re-template a pre-existing MRP1 dominant profile in recipient cells. These findings have significance in understanding the molecular basis for tumour dominant phenotypes and introduce potential new strategies and targets for the acquisition of MDR and other deleterious traits.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ct; FCM; Intercellular transfer; MDR; MFI; MPs; MRP1; Microparticles; Multidrug Resistance-Associated Protein 1; Multidrug resistance; P-glycoprotein; P-gp; PBC; Re-templating; Trait dominance; a.u.; arbitrary units; cycle threshold; flow cytometry; mean fluorescence intensity; microparticles; multidrug resistance; probenecid; qRT-PCR; quantitative real-time PCR

Mesh:

Substances:

Year:  2013        PMID: 23917219     DOI: 10.1016/j.phrs.2013.07.009

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  36 in total

Review 1.  Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.

Authors:  Rajendra Awasthi; Michael John Rathbone; Philip Michael Hansbro; Mary Bebawy; Kamal Dua
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

Review 2.  Mechanisms of tumor cell resistance to the current targeted-therapy agents.

Authors:  Gholamreza Khamisipour; Farhad Jadidi-Niaragh; Abdolreza Sotoodeh Jahromi; Keivan Zandi; Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2016-05-07

3.  Extracellular Vesicles in Chemoresistance.

Authors:  Gabriele De Rubis; Mary Bebawy
Journal:  Subcell Biochem       Date:  2021

4.  A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells.

Authors:  Jamie F Lu; Deep Pokharel; Mary Bebawy
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

Review 5.  Membrane microparticles: shedding new light into cancer cell communication.

Authors:  Paloma Silva de Souza; Roberta Soares Faccion; Paula Sabbo Bernardo; Raquel Ciuvalschi Maia
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-19       Impact factor: 4.553

Review 6.  Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?

Authors:  Richard Callaghan; Frederick Luk; Mary Bebawy
Journal:  Drug Metab Dispos       Date:  2014-02-03       Impact factor: 3.922

7.  Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.

Authors:  Priya Samuel; Laura Ann Mulcahy; Fiona Furlong; Helen O McCarthy; Susan Ann Brooks; Muller Fabbri; Ryan Charles Pink; David Raul Francisco Carter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

Review 8.  Sorting it out: regulation of exosome loading.

Authors:  Carolina Villarroya-Beltri; Francesc Baixauli; Cristina Gutiérrez-Vázquez; Francisco Sánchez-Madrid; María Mittelbrunn
Journal:  Semin Cancer Biol       Date:  2014-04-23       Impact factor: 15.707

Review 9.  Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research.

Authors:  Yan Hu; Yajie Sun; Chao Wan; Xiaomeng Dai; Shuhui Wu; Pui-Chi Lo; Jing Huang; Jonathan F Lovell; Honglin Jin; Kunyu Yang
Journal:  J Nanobiotechnology       Date:  2022-04-13       Impact factor: 10.435

Review 10.  Microparticles That Form Immune Complexes as Modulatory Structures in Autoimmune Responses.

Authors:  Catalina Burbano; Mauricio Rojas; Gloria Vásquez; Diana Castaño
Journal:  Mediators Inflamm       Date:  2015-08-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.